Need to address all market opportunities opening up for us, says Biocon

Biocon is in focus as reports indicate that PE firms Temasek and True North along with Canadian Pension Fund are looking to invest in the company's biologics business. Kiran Mazumdar Shaw, CMD of Biocon shared her views and outlook.